Cogent Biosciences Stock (NASDAQ: COGT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.131M |
Day Range | - - - |
52 Wk Range | 3.670 - 13.500 |
Market Cap | $574.637M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 12.76% |
Days to Cover | 7.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cogent Biosciences (NASDAQ: COGT) through any online brokerage.
Other companies in Cogent Biosciences’s space includes: Cabaletta Bio (NASDAQ:CABA), ARS Pharmaceuticals (NASDAQ:SPRY), Korro Bio (NASDAQ:KRRO), Pharming (NASDAQ:PHAR) and Mesoblast (NASDAQ:MESO).
The latest price target for Cogent Biosciences (NASDAQ: COGT) was reported by JP Morgan on Tuesday, February 27, 2024. The analyst firm set a price target for 20.00 expecting COGT to rise to within 12 months (a possible 232.78% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Cogent Biosciences (NASDAQ: COGT) is $6.01 last updated April 25, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Cogent Biosciences.
Cogent Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Cogent Biosciences.
Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.